公司資料
Doximity 股價、新聞與催化劑
- 股票代碼:
- DOCS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
28.50 USD (+0.56%)
收盤價
最後更新: 2026年10月1日
3.93B USD
市值
股價為何變動
截至 2026年10月1日，DOCS 上漲 0.56%，收於 $28.50。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Digital Network for Medical Professionals
Doximity operates a verified professional platform used by more than 85% of U.S. physicians. Members use the network to communicate with colleagues, follow medical news and research, manage careers and schedules, and access clinical workflow tools.
Clinical Communication Tools
Dialer supports secure calls, video visits, voicemail, and text workflows, while the platform also provides digital faxing and other administrative tools. These products are designed around clinicians' existing identities and practice workflows.
Clinical AI Suite
Doximity Ask provides evidence-backed medical search and clinical assistance, PeerCheck incorporates physician review, and Scribe supports ambient documentation. The products are designed for healthcare use and can be integrated into partner practice platforms.
Scheduling and Workflow Products
Amion supports on-call scheduling, while prescription research and other workflow functions help clinicians complete frequent administrative and clinical tasks within a single professional environment.
Life-Sciences Commercial Model
Doximity monetizes its clinician audience primarily through pharmaceutical and health-system customers seeking targeted digital engagement. Its verified membership, specialty data, and workflow usage create a differentiated channel for reaching medical professionals.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。